SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 21, 2000
MEDICALOGIC/MEDSCAPE, INC.
(Exact name of registrant as specified in its charter)
| Oregon (State or other jurisdiction incorporation or organization) | 000-28285 (Commission File Number) | 93-0890696 (I.R.S. Employer Identification No.) |
20500 NW Evergreen Parkway
Hillsboro, Oregon 97124
(Address of principal executive offices)
(503) 531-7000
(Registrant's telephone number,
including area code)
Item 5. Other Events
On December 21, 2000 MedicaLogic/Medscape, Inc. (the "Company") announced an agreement for a $17.3 million private placement of preferred stock and warrants. The Company's press release is attached hereto as Exhibit 99.1.
Item 7. Financial Statements and Exhibits
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: December 21, 2000 | MEDICALOGIC/MEDSCAPE, INC. | |||
By: | /s/ MARK E. BOULDING Mark E. Boulding General Counsel, Executive Vice President, Governmental & Regulatory Affairs and Secretary |
2
| Exhibit | Description | |
|---|---|---|
| 99.1 | Press release dated December 21, 2000 |
3
